| Expert Panel Curation of 31 Genes in Relation to Limb Girdle Muscular Dystrophy S Mohan, S McNulty, C Thaxton, M Elnagheeb, E Owens, M Flowers, ... bioRxiv, 2024.05. 03.592369, 2024 | | 2024 |
| 266th ENMC International Workshop: Remote delivery of clinical care and validation of remote clinical outcome assessments in neuromuscular disorders: A response to COVID-19 and … LN Alfano, MK James, GM Ramdharry, LP Lowes, J Coats, J Corderí, ... Neuromuscular Disorders 33 (4), 339-348, 2023 | | 2023 |
| The TREAT NMD LGMD Global Registry development S Segovia, L Alfano, G Comi, M Casado, JD Manera, R El Sherif, ... EUROPEAN JOURNAL OF NEUROLOGY 28, 330-330, 2021 | | 2021 |
| Coalition to cure calpain 3: A patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer NEUROMUSCULAR DISORDERS 30, S145-S145, 2020 | | 2020 |
| REGISTRIES, CARE, QUALITY OF LIFE, MANAGEMENT OF NMD: P. 340 Coalition to cure calpain 3: A patient organization committed to treating and ultimately curing limb girdle … J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer Neuromuscular Disorders 30, S145, 2020 | | 2020 |
| Coalition to cure calpain 3: a patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer NEUROMUSCULAR DISORDERS 29, S196-S197, 2019 | | 2019 |
| P. 394Coalition to cure calpain 3: a patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer Neuromuscular Disorders 29, S196-S197, 2019 | | 2019 |
| Coalition to Cure Calpain 3: a patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer NEUROMUSCULAR DISORDERS 28, S60-S61, 2018 | | 2018 |
| LGMD AUTOSOMAL RESSESSIVE AND DOMINANT: P. 104Coalition to Cure Calpain 3: a patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer Neuromuscular Disorders 28, S60-S61, 2018 | | 2018 |
| 233rd ENMC International Workshop:: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017 W Lostal, JA Urtizberea, I Richard, A Alonso-Jiménez, RY Carlier, ... Neuromuscular Disorders, 2018 | 4 | 2018 |
| Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers ML Cox, JM Evans, AG Davis, LT Guo, JR Levy, AN Starr-Moss, ... Skeletal muscle 7 (1), 15, 2017 | 22 | 2017 |
| Coalition to cure calpain 3: A patient organization committed to treating and ultimately curing limb girdle muscular dystrophy type 2A J Levy, J Boslego, M Wrubel, L Wrubel, M Spencer Neuromuscular Disorders 26, S91, 2016 | | 2016 |
| Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse JC de Greef, R Hamlyn, BS Jensen, R O'Campo Landa, JR Levy, ... Human molecular genetics 25 (7), 1357-1369, 2016 | 19 | 2016 |
| Effects of CaMKII activity on cardiac and skeletal muscle pathology in a mouse model of Duchenne muscular dystrophy (1102.3) N Johnson, J Levy, I Grumbach, M Anderson, K Campbell The FASEB Journal 28 (1_supplement), 1102.3, 2014 | | 2014 |
| MG53 [prime] s new identity. JR Levy, KP Campbell, DJ Glass Skeletal Muscle 3 (1), 2013 | | 2013 |
| MG53′ s new identity JR Levy, KP Campbell, DJ Glass Skeletal muscle 3 (1), 25, 2013 | 15 | 2013 |
| Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy JR Levy, KP Campbell The Journal of clinical investigation 123 (5), 1931-1934, 2013 | 1 | 2013 |
| Rate of force recovery immediately following lengthening contractions for various mouse models of muscular dystrophy EP Rader, R Han, JR Levy, D Bansal, KP Campbell The FASEB Journal 26, 1141.6, 2012 | | 2012 |
| Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice R Han, EP Rader, JR Levy, D Bansal, KP Campbell Skeletal muscle 1 (1), 35, 2011 | 66 | 2011 |
| Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice R Han, EM Frett, JR Levy, EP Rader, JD Lueck, D Bansal, SA Moore, ... The Journal of clinical investigation 120 (12), 4366-4374, 2010 | 107 | 2010 |
